A new study indicates that there is an increased risk for cerebral microbleeds among adults who have moderate to severe ...

A new study published in JAMA Network Open has shown that moderate to severe obstructive sleep apnea is associated with a significantly increased risk for future cerebral microbleeds. The ...

Research led by Korea University Ansan Hospital reports finding an association between moderate to severe obstructive sleep apnea and increased risk of cerebral microbleeds. Cerebral microbleeds ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

Please provide your email address to receive an email when new articles are posted on . Individuals with moderate to severe obstructive sleep apnea had increased odds of having neovascular AMD.

Repeated pauses in breathing at night can cause oxygen deprivation , sudden rises in blood pressure and microvascular injury ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...

The American Academy of Sleep Medicine has indicated that an estimated 26 percent of adults between the ages of 30 and 70 years have sleep apnea. (Photo: Getty) You could say that it’s difficult to ...

Please provide your email address to receive an email when new articles are posted on . Researchers found heightened odds for mortality among veterans with no sleep apnea vs. with mild to moderate ...

Sleep apnea -- even if it is so mild that people have no daytime drowsiness -- may increase the risk of cardiovascular disease, a study shows. The study, published in the American Journal of ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better manage their type 2 diabetes. And as of December 20, Eli Lilly’s weight loss ...